Exhibit 10.2


 


Option No.________


 


CYCLACEL PHARMACEUTICALS, INC.


 


Stock Option Grant Notice


Stock Option Grant under the Company’s


2015 Equity Incentive Plan


 


	1.	Name and Address of Participant:	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	2.	Date of Option Grant:	 	 
	 	 	 	 
	3.	Type of Grant:	 	 
	 	 	 	 
	4.	Maximum Number of Shares for which this Option is exercisable:	 	 
	 	 	 	 
	5.	Exercise (purchase) price per share:	 	 
	 	 	 	 
	6.	Option Expiration Date1:	 	 
	 	 	 	 
	7.	Vesting Start Date2:	 	 
	 	 	 	 
	8.	Vesting Schedule:  This Option shall become exercisable (and the Shares issued upon exercise shall be vested) as follows provided the Participant is an Employee, director or Consultant of the Company or of an Affiliate on the applicable vesting date:


 


[Insert Vesting Schedule - sample
below]3


 


	[On the first anniversary of the Vesting Start Date	 	up to ____________ Shares4


 





 






1
This date must be within 10 years of the date of grant


2 This date is only necessary if the company has decided
to trigger vesting from a date that is different from the date of option grant such as a hire date and is to be used as a point
of reference for future vesting only.


3 An option may provide for performance-based
vesting instead of time-based vesting. The performance criteria can be related to stock price performance or other pre-established
company-wide or individual goals.  If related to stock price performance pursuant to FAS 123(R) the option will be subject
to liability accounting (marked to market) instead of equity accounting.


4 If the agreement does not set forth a vesting schedule
as to a specific number of shares and a % is used instead consider adding the following to the end of the vesting schedule to address
the potential vesting of fractional shares:


“provided that the number of shares vesting on each date shall
be rounded down to the nearest whole number, whilst the number of shares vesting on the final date shall be the remaining unvested
balance of the Shares.”


 





    	 



    	 



    

 


	On the second anniversary of the Vesting Start Date	 	an additional __________ Shares
	 	 	 
	On the third anniversary of the Vesting Start Date	 	an additional __________ Shares]


 


The foregoing rights are
cumulative and are subject to the other terms and conditions of this Agreement and the Plan.


 


The Company and the Participant acknowledge
receipt of this Stock Option Grant Notice and agree to the terms of the Stock Option Agreement attached hereto and incorporated
by reference herein, the Company’s 2015 Equity Incentive Plan and the terms of this Option Grant as set forth above.


 





	 	CYCLACEL PHARMACEUTICALS, INC.
	 	 	 
	 	 	By:	
	 	 	 	Name:	 
	 	 	 	Title:	 
	 	 	 
	 	 	 
	 	 	Participant













 




    	2



    	 



    

 


CYCLACEL PHARMACEUTICALS, INC.


 


STOCK OPTION AGREEMENT - INCORPORATED
TERMS AND CONDITIONS


 


AGREEMENT made as of the
date of grant set forth in the Stock Option Grant Notice by and between Cyclacel Pharmaceuticals, Inc. (the “Company”),
a Delaware corporation, and the individual whose name appears on the Stock Option Grant Notice (the “Participant”).


 


WHEREAS, the Company desires
to grant to the Participant an Option to purchase shares of its common stock, $0.001 par value per share (the “Shares”),
under and for the purposes set forth in the Company’s 2015 Equity Incentive Plan (the “Plan”);


 


WHEREAS, the Company and
the Participant understand and agree that any terms used and not defined herein have the same meanings as in the Plan; and


 


WHEREAS, the Company and
the Participant each intend that the Option granted herein shall be of the type set forth in the Stock Option Grant Notice.


 


NOW, THEREFORE, in consideration
of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto agree as follows:


 


1.           GRANT OF OPTION.


 


The Company hereby grants
to the Participant the right and option to purchase all or any part of an aggregate of the number of Shares set forth in the Stock
Option Grant Notice, on the terms and conditions and subject to all the limitations set forth herein, under United States securities
and tax laws, and in the Plan, which is incorporated herein by reference.  The Participant acknowledges receipt of a
copy of the Plan.


 


2.            EXERCISE PRICE.


 


The exercise price of the
Shares covered by the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject to adjustment, as
provided in the Plan, in the event of a stock split, reverse stock split or other events affecting the holders of Shares after
the date hereof (the “Exercise Price”).  Payment shall be made in accordance with Paragraph 10 of
the Plan.


 


3.            EXERCISABILITY OF OPTION.


 


Subject to the terms and
conditions set forth in this Agreement and the Plan, the Option granted hereby shall become vested and exercisable as set forth
in the Stock Option Grant Notice and is subject to the other terms and conditions of this Agreement and the Plan.


 




    	 



    	 



    

 


		4.	TERM OF OPTION.



 


This Option shall terminate
on the Option Expiration Date as specified in the Stock Option Grant Notice and, if this Option is designated in the Stock Option
Grant Notice as an ISO and the Participant owns as of the date hereof more than 10% of the total combined voting power of all classes
of capital stock of the Company or an Affiliate, such date may not be more than five years from the date of this Agreement, but
shall be subject to earlier termination as provided herein or in the Plan.


 


If the Participant ceases
to be an Employee, director or Consultant of the Company or of an Affiliate for any reason other than the death or Disability
of the Participant, or termination of the Participant for Cause (the “Termination Date”), the Option to the extent
then vested and exercisable pursuant to Section 3 hereof as of the Termination Date, and not previously terminated in accordance
with this Agreement, may be exercised within [three]5
months after the Termination Date, or on or prior to the Option Expiration Date as specified in the Stock Option
Grant Notice, whichever is earlier, but may not be exercised thereafter except as set forth below.  In such event, the
unvested portion of the Option shall not be exercisable and shall expire and be cancelled on the Termination Date.


 


If this Option is designated
in the Stock Option Grant Notice as an ISO and the Participant ceases to be an Employee of the Company or of an Affiliate but continues
after termination of employment to provide service to the Company or an Affiliate as a director or Consultant, this Option shall
continue to vest in accordance with Section 3 above as if this Option had not terminated until the Participant is no longer providing
services to the Company.  In such case, this Option shall automatically convert and be deemed a Non-Qualified Option
as of the date that is three months from termination of the Participant's employment and this Option shall continue on the same
terms and conditions set forth herein until such Participant is no longer providing service to the Company or an Affiliate.


 


Notwithstanding the foregoing,
in the event of the Participant’s Disability or death within three months after the Termination Date, the Participant or
the Participant’s Survivors may exercise the Option within one year after the Termination Date, but in no event after the
Option Expiration Date as specified in the Stock Option Grant Notice.


 


In the event the Participant’s
service is terminated by the Company or an Affiliate for Cause, the Participant’s right to exercise any unexercised portion
of this Option even if vested shall cease immediately as of the time the Participant is notified his or her service is terminated
for Cause, and this Option shall thereupon terminate.  Notwithstanding anything herein to the contrary, if subsequent
to the Participant’s termination, but prior to the exercise of the Option, the Administrator determines that, either prior
or subsequent to the Participant’s termination, the Participant engaged in conduct which would constitute Cause, then the


 





 






5 Three months is the maximum time period for an ISO.  If
the time period is longer, any option exercised more than three months after the individual ceases to be an employee of the company
shall be deemed pursuant to the Code to be a non-qualified stock option.


 




    	2



    	 



    

 


Participant shall immediately cease to have
any right to exercise the Option and this Option shall thereupon terminate.


 


In the event of the Disability
of the Participant, as determined in accordance with the Plan, the Option shall be exercisable within one year after the Participant’s
termination of service due to Disability or, if earlier, on or prior to the Option Expiration Date as specified in the Stock Option
Grant Notice.  In such event, the Option shall be exercisable:


 


		(a)	to the extent that the Option has become exercisable but has not been exercised as of the date
of the Participant’s termination of service due to Disability; and



 


		(b)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion
through the date of the Participant’s termination of service due to Disability of any additional vesting rights that would
have accrued on the next vesting date had the Participant not become Disabled.  The proration shall be based upon the
number of days accrued in the current vesting period prior to the date of the Participant’s termination of service due to
Disability.



 


In the event of the death
of the Participant while an Employee, director or Consultant of the Company or of an Affiliate, the Option shall be exercisable
by the Participant’s Survivors within one year after the date of death of the Participant or, if earlier, on or prior to
the Option Expiration Date as specified in the Stock Option Grant Notice.  In such event, the Option shall be exercisable:


 


		(x)	to the extent that the Option has become exercisable but has not been exercised as of the date
of death; and



 


		(y)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion
through the date of death of any additional vesting rights that would have accrued on the next vesting date had the Participant
not died.  The proration shall be based upon the number of days accrued in the current vesting period prior to the Participant’s
date of death.



 


5.            METHOD OF EXERCISING
OPTION.


 


Subject to the terms and
conditions of this Agreement, the Option may be exercised by written notice to the Company or its designee, in substantially the
form of Exhibit A attached hereto (or in such other form acceptable to the Company, which may include electronic notice).  Such
notice shall state the number of Shares with respect to which the Option is being exercised and shall be signed by the person exercising
the Option (which signature may be provided electronically in a form acceptable to the Company).  Payment of the Exercise
Price for such Shares shall be made in accordance with Paragraph 10 of the Plan.  The Company shall deliver such Shares
as soon as practicable after the notice shall be received, provided, however, that the Company may delay issuance of such Shares
until completion of any action or obtaining


 




    	3



    	 



    

 


of any consent, which the Company deems necessary
under any applicable law (including, without limitation, state securities or “blue sky” laws).  The Shares
as to which the Option shall have been so exercised shall be registered in the Company’s share register in the name of the
person so exercising the Option (or, if the Option shall be exercised by the Participant and if the Participant shall so request
in the notice exercising the Option, shall be registered in the Company’s share register in the name of the Participant and
another person jointly, with right of survivorship) and shall be delivered as provided above to or upon the written order of the
person exercising the Option.  In the event the Option shall be exercised, pursuant to Section 4 hereof, by any person
other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option.  All
Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid and nonassessable.


 


		6.	PARTIAL EXERCISE.



 


Exercise of this Option to
the extent above stated may be made in part at any time and from time to time within the above limits, except that no fractional
share shall be issued pursuant to this Option.


 


		7.	NON-ASSIGNABILITY.



 


The Option shall not be transferable
by the Participant otherwise than by will or by the laws of descent and distribution.  If this Option is a Non-Qualified
Option then it may also be transferred pursuant to a qualified domestic relations order as defined by the Code or Title I of the
Employee Retirement Income Security Act or the rules thereunder. Except as provided above in this paragraph, the Option shall be
exercisable, during the Participant’s lifetime, only by the Participant (or, in the event of legal incapacity or incompetency,
by the Participant’s guardian or representative) and shall not be assigned, pledged or hypothecated in any way (whether by
operation of law or otherwise) and shall not be subject to execution, attachment or similar process.  Any attempted transfer,
assignment, pledge, hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions
of this Section 7, or the levy of any attachment or similar process upon the Option shall be null and void.


 


		8.	NO RIGHTS AS STOCKHOLDER UNTIL EXERCISE.



 


The Participant shall have
no rights as a stockholder with respect to Shares subject to this Agreement until registration of the Shares in the Company’s
share register in the name of the Participant.  Except as is expressly provided in the Plan with respect to certain changes
in the capitalization of the Company, no adjustment shall be made for dividends or similar rights for which the record date is
prior to the date of such registration.


 


		9.	ADJUSTMENTS.



 


The Plan contains provisions
covering the treatment of Options in a number of contingencies such as stock splits and mergers.  Provisions in the Plan
for adjustment with respect to stock subject to Options and the related provisions with respect to successors to the business of
the Company are hereby made applicable hereunder and are incorporated herein by


 




    	4



    	 



    

 


reference, including, but not limited
to, the change of control acceleration of vesting provision contained in Paragraph 25(g) of the Plan.


 


		10.	TAXES.



 


The Participant acknowledges
that any income or other taxes due from him or her with respect to this Option or the Shares issuable pursuant to this Option shall
be the Participant’s responsibility.  The Participant acknowledges and agrees that (i) the Participant was free
to use professional advisors of his or her choice in connection with this Agreement, has received advice from his or her professional
advisors in connection with this Agreement, understands its meaning and import, and is entering into this Agreement freely and
without coercion or duress; (ii) the Participant has not received and is not relying upon any advice, representations or assurances
made by or on behalf of the Company or any Affiliate or any employee of or counsel to the Company or any Affiliate regarding any
tax or other effects or implications of the Option, the Shares or other matters contemplated by this Agreement; and (iii) neither
the Administrator, the Company, its Affiliates, nor any of its officers or directors, shall be held liable for any applicable costs,
taxes, or penalties associated with the Option if, in fact, the Internal Revenue Service were to determine that the Option constitutes
deferred compensation under Section 409A of the Code.


 


If this Option is designated
in the Stock Option Grant Notice as a Non-Qualified Option or if the Option is an ISO and is converted into a Non-Qualified Option
and such Non-Qualified Option is exercised, the Participant agrees that the Company may withhold from the Participant’s remuneration,
if any, the minimum statutory amount of federal, state and local withholding taxes attributable to such amount that is considered
compensation includable in such person’s gross income.  At the Company’s discretion, the amount required
to be withheld may be withheld in cash from such remuneration, or in kind from the Shares otherwise deliverable to the Participant
on exercise of the Option.  The Participant further agrees that, if the Company does not withhold an amount from the
Participant’s remuneration sufficient to satisfy the Company’s income tax withholding obligation, the Participant will
reimburse the Company on demand, in cash, for the amount under-withheld.


 


		11.	PURCHASE FOR INVESTMENT.



 


Unless the offering and sale
of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered under the Securities
Act, the Company shall be under no obligation to issue the Shares covered by such exercise unless the Company has determined that
such exercise and issuance would be exempt from the registration requirements of the Securities Act and until the following conditions
have been fulfilled:


 


		(a)	The person(s) who exercise the Option shall warrant to the Company, at the time of such exercise,
that such person(s) are acquiring such Shares for their own respective accounts, for investment, and not with a view to, or for
sale in connection with, the distribution of any such Shares, in which event the person(s) acquiring such Shares shall be bound
by the provisions



 




    	5



    	 



    

 


of the following legend which shall
be endorsed upon any certificate(s) evidencing the Shares issued pursuant to such exercise:


 


“The shares represented by
this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee,
unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933,
as amended, or (b) the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration
under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws;” and


 


(b)If the Company so requires,
the Company shall have received an opinion of its counsel that the Shares may be issued upon such particular exercise in compliance
with the Securities Act without registration thereunder.  Without limiting the generality of the foregoing, the Company
may delay issuance of the Shares until completion of any action or obtaining of any consent, which the Company deems necessary
under any applicable law (including without limitation state securities or “blue sky” laws).


 


		12.	RESTRICTIONS ON TRANSFER OF SHARES.



 


12.1       The Participant
agrees that in the event the Company proposes to offer for sale to the public any of its equity securities and such Participant
is requested by the Company and any underwriter engaged by the Company in connection with such offering to sign an agreement restricting
the sale or other transfer of Shares, then it will promptly sign such agreement and will not transfer, whether in privately negotiated
transactions or to the public in open market transactions or otherwise, any Shares or other securities of the Company held by him
or her during such period as is determined by the Company and the underwriters, not to exceed 180 days following the closing of
the offering, plus such additional period of time as may be required to comply with Marketplace Rule 2711 of the National Association
of Securities Dealers, Inc. or similar rules thereto (such period, the “Lock-Up Period”).  Such agreement
shall be in writing and in form and substance reasonably satisfactory to the Company and such underwriter and pursuant to customary
and prevailing terms and conditions.  Notwithstanding whether the Participant has signed such an agreement, the Company
may impose stop-transfer instructions with respect to the Shares or other securities of the Company subject to the foregoing restrictions
until the end of the Lock-Up Period.


 


12.2         The Participant
acknowledges and agrees that neither the Company, its shareholders nor its directors and officers, has any duty or obligation to
disclose to the Participant any material information regarding the business of the Company or affecting the value of the Shares
before, at the time of, or following a termination of the service of the Participant by the Company, including, without limitation,
any information concerning plans for the Company to make a public offering of its securities or to be acquired by or merged with
or into another firm or entity.


 




    	6



    	 



    

 


		13.	NO OBLIGATION TO MAINTAIN RELATIONSHIP.



 


The Participant acknowledges
that: (i) the Company is not by the Plan or this Option obligated to continue the Participant as an employee, director or Consultant
of the Company or an Affiliate; (ii) the Plan is discretionary in nature and may be suspended or terminated by the Company at any
time; (iii) the grant of the Option is a one-time benefit which does not create any contractual or other right to receive future
grants of options, or benefits in lieu of options; (iv) all determinations with respect to any such future grants, including, but
not limited to, the times when options shall be granted, the number of shares subject to each option, the option price, and the
time or times when each option shall be exercisable, will be at the sole discretion of the Company; (v) the Participant’s
participation in the Plan is voluntary; (vi) the value of the Option is an extraordinary item of compensation which is outside
the scope of the Participant’s employment or consulting contract, if any; and (vii) the Option is not part of normal or expected
compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service
awards, pension or retirement benefits or similar payments.


 


		14.	IF OPTION IS INTENDED TO BE AN ISO.



 


If this Option is designated
in the Stock Option Grant Notice as an ISO so that the Participant (or the Participant’s Survivors) may qualify for the favorable
tax treatment provided to holders of Options that meet the standards of Section 422 of the Code then any provision of this Agreement
or the Plan which conflicts with the Code so that this Option would not be deemed an ISO is null and void and any ambiguities shall
be resolved so that the Option qualifies as an ISO.  The Participant should consult with the Participant’s own
tax advisors regarding the tax effects of the Option and the requirements necessary to obtain favorable tax treatment under Section
422 of the Code, including, but not limited to, holding period requirements.


 


Notwithstanding the foregoing,
to the extent that the Option is designated in the Stock Option Grant Notice as an ISO and is not deemed to be an ISO pursuant
to Section 422(d) of the Code because the aggregate Fair Market Value (determined as of the Date of Option Grant) of any of the
Shares with respect to which this ISO is granted becomes exercisable for the first time during any calendar year in excess of $100,000,
the portion of the Option representing such excess value shall be treated as a Non-Qualified Option and the Participant shall be
deemed to have taxable income measured by the difference between the then Fair Market Value of the Shares received upon exercise
and the price paid for such Shares pursuant to this Agreement.


 


Neither the Company nor any
Affiliate shall have any liability to the Participant, or any other party, if the Option (or any part thereof) that is intended
to be an ISO is not an ISO or for any action taken by the Administrator, including without limitation the conversion of an ISO
to a Non-Qualified Option.


 




    	7



    	 



    

 


		15.	NOTICE TO COMPANY OF DISQUALIFYING DISPOSITION OF AN ISO.



 


If this Option is designated
in the Stock Option Grant Notice as an ISO then the Participant agrees to notify the Company in writing immediately after the Participant
makes a Disqualifying Disposition of any of the Shares acquired pursuant to the exercise of the ISO.  A Disqualifying
Disposition is defined in Section 424(c) of the Code and includes any disposition (including any sale) of such Shares before the
later of (a) two years after the date the Participant was granted the ISO or (b) one year after the date the Participant acquired
Shares by exercising the ISO, except as otherwise provided in Section 424(c) of the Code.  If the Participant has died
before the Shares are sold, these holding period requirements do not apply and no Disqualifying Disposition can occur thereafter.


 


		16.	NOTICES.



 


Any notices required or permitted
by the terms of this Agreement or the Plan shall be given by recognized courier service, facsimile, registered or certified mail,
return receipt requested, addressed as follows:


 


If to the Company:


 


Cyclacel Pharmaceuticals, Inc.

200 Connell Drive, Suite 1500

Berkeley Heights, New Jersey 07922


Attention: [  ]


 


If to the Participant at the address set forth on the Stock Option
Grant Notice


 


or to such other address or addresses of which notice in the same
manner has previously been given.  Any such notice shall be deemed to have been given upon the earlier of receipt, one
business day following delivery to a recognized courier service or three business days following mailing by registered or certified
mail.


 


		17.	GOVERNING LAW.



 


This Agreement shall be governed
by and construed in accordance with the laws of the Delaware, without giving effect to the conflict of law principles thereof.  For
the purpose of litigating any dispute that arises under this Agreement, the parties hereby consent to exclusive jurisdiction in
New Jersey and agree that such litigation shall be conducted in the state courts of New Jersey or the federal courts
of the United States for the District of New Jersey.


 


		18.	BENEFIT OF AGREEMENT.



 


Subject to the provisions
of the Plan and the other provisions hereof, this Agreement shall be for the benefit of and shall be binding upon the heirs, executors,
administrators, successors and assigns of the parties hereto.


 




    	8



    	 



    

 


		19.	ENTIRE AGREEMENT.



 


This Agreement, together
with the Plan, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof
and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.  No statement,
representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret,
change or restrict, the express terms and provisions of this Agreement, provided, however, in any event, this Agreement shall be
subject to and governed by the Plan.


 




    	9



    	 



    

 


		20.	MODIFICATIONS AND AMENDMENTS.



 


The terms and provisions
of this Agreement may be modified or amended as provided in the Plan.


 


		21.	WAIVERS AND CONSENTS.



 


Except as provided in the
Plan, the terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written
document executed by the party entitled to the benefits of such terms or provisions.  No such waiver or consent shall
be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether
or not similar.  Each such waiver or consent shall be effective only in the specific instance and for the purpose for
which it was given, and shall not constitute a continuing waiver or consent.


 


22.          DATA PRIVACY.


 


By entering into this Agreement,
the Participant: (i) authorizes the Company and each Affiliate, and any agent of the Company or any Affiliate administering the
Plan or providing Plan recordkeeping services, to disclose to the Company or any of its Affiliates such information and data as
the Company or any such Affiliate shall request in order to facilitate the grant of options and the administration of the Plan;
and (ii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set
forth in this Agreement.


 


[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]


 




    	10



    	 



    

 


Exhibit A


 


NOTICE OF EXERCISE OF STOCK OPTION


 


[Form for Shares registered in the
United States]


 


To:     Cyclacel Pharmaceuticals, Inc.


 


IMPORTANT NOTICE: This form of Notice of Exercise may only be used
at such time as the Company has filed a Registration Statement with the Securities and Exchange Commission under which the issuance
of the Shares for which this exercise is being made is registered and such Registration Statement remains effective.


 


Ladies and Gentlemen:


 


I hereby exercise my Stock
Option to purchase _________ shares (the “Shares”) of the common stock, $0.001 par value, of Cyclacel Pharmaceuticals,
Inc. (the “Company”), at the exercise price of $________ per share, pursuant to and subject to the terms of
that Stock Option Grant Notice dated _______________, 201_.


 


I understand the nature
of the investment I am making and the financial risks thereof.  I am aware that it is my responsibility to have consulted
with competent tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the
exercise of the Option and the purchase and subsequent sale of the Shares.


 


I am paying the option
exercise price for the Shares as follows:





 


	 






 


Please issue the Shares (check one):


 


 ̈ to me;
or


 


 ̈
to me and ____________________________, as joint tenants with right of survivorship,


 


at the following address:


 


	 	 	 
	 	 	 
	 	 	 


 




    	Exhibit A-1



    	 



    

 


My mailing address for
shareholder communications, if different from the address listed above, is:


 


	 	 	 
	 	 	 
	 	 	 


 


	 	Very truly yours,
	 	 
	 	 
	 	Participant (signature)
	 	 
	 	 
	 	Print Name
	 	 
	 	 
	 	Date


 




    	Exhibit A-2